ZFIN Person: Sacilotto, Natalia

ZFIN ID: ZDB-PERS-131112-13

Sacilotto, Natalia

Email:	natalia.sacilotto@ludwig.ox.ac.uk
URL:
Affiliation:	De Val Lab
Address:
Country:	UK
Phone:
Fax:
ORCID ID:

BIOGRAPHY AND RESEARCH INTERESTS

PUBLICATIONS

Overman, J., Fontaine, F., Moustaqil, M., Mittal, D., Sierecki, E., Sacilotto, N., Zuegg, J., Robertson, A.A.B., Holmes, K., Salim, A.A., Mamidyala, S., Butler, M.S., Robinson, A.S., Lesieur, E., Johnston, W., Alexandrov, K., Black, B.L., Hogan, B.M., De Val, S., Capon, R.J., Carroll, J.S., Bailey, T.L., Koopman, P., Jauch, R., Cooper, M.A., Gambin, Y., Francois, M. (2023) Correction: Pharmacological targeting of the transcription factor SOX18 delays breast cancer in mice. eLIFE. 12

Neal, A., Nornes, S., Louphrasitthiphol, P., Sacilotto, N., Preston, M.D., Fleisinger, L., Payne, S., De Val, S. (2021) ETS factors are required but not sufficient for specific patterns of enhancer activity in different endothelial subtypes. Developmental Biology. 473:1-14

Overman, J., Fontaine, F., Moustaqil, M., Mittal, D., Sierecki, E., Sacilotto, N., Zuegg, J., Robertson, A.A., Holmes, K., Salim, A.A., Mamidyala, S., Butler, M.S., Robinson, A.S., Lesieur, E., Johnston, W., Alexandrov, K., Black, B.L., Hogan, B.M., Val, S., Capon, R.J., Carroll, J.S., Bailey, T.L., Koopman, P., Jauch, R., Smyth, M.J., Cooper, M.A., Gambin, Y., Francois, M. (2017) Pharmacological targeting of the transcription factor SOX18 delays breast cancer in mice. eLIFE. 6

Sacilotto, N., Chouliaras, K.M., Nikitenko, L.L., Lu, Y.W., Fritzsche, M., Wallace, M.D., Nornes, S., García-Moreno, F., Payne, S., Bridges, E., Liu, K., Biggs, D., Ratnayaka, I., Herbert, S.P., Molnár, Z., Harris, A.L., Davies, B., Bond, G.L., Bou-Gharios, G., Schwarz, J.J., De Val, S. (2016) MEF2 transcription factors are key regulators of sprouting angiogenesis. Genes & Development. 30:2297-2309

Becker, P.W., Sacilotto, N., Nornes, S., Neal, A., Thomas, M., Liu, K., Preece, C., Ratnayaka, I., Davies, B., Bou-Gharios, G., De Val, S. (2016) Intronic Flk1 Enhancer Directs Arterial-Specific Expression via RBPJ-Mediated Venous Repression. Arteriosclerosis, Thrombosis, and Vascular Biology. 36(6):1209-19

NON-ZEBRAFISH PUBLICATIONS